| Jennifer Lentz has been the Global Informed Consent Process Owner at Eli Lilly and Company for the last 3.5 years. This has included the global implementation of electronic consent. Currently, she is also involved in external consent projects with Clinical Trials Transformation Initiative and Transcelerate. Her previous roles at Lilly have included United States Informed Consent Subject Matter Expert and Site Activation Management Associate. Prior to joining Lilly, Jennifer worked as a study monitor, study coordinator, disease management field investigator, and lab researcher. She became interested in informed consent during her involvement as a pediatric and adult research subject. She has a B.S. in Biology from Ball State University. |